Evaluation of iron overload

British Journal of Haematology

Volumn 124, Issue 6, 2004, Pages 697-711

  Jensen, Peter D ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Cardiac iron; Hepatic iron; Iron overload; Magnetic resonance imaging

Indexed keywords

CHELATING AGENT; DEFEROXAMINE; IRON;

AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; BETA THALASSEMIA; BLOOD TRANSFUSION; CHELATION THERAPY; COMPUTER ASSISTED TOMOGRAPHY; DRUG SCREENING; DYSERYTHROPOIESIS; ERYTHROPOIESIS; FERRITIN BLOOD LEVEL; HUMAN; HYPOXIA; INTESTINE ABSORPTION; IRON ABSORPTION; IRON CHELATION; IRON OVERLOAD; LIVER BIOPSY; LIVER CELL DAMAGE; MAGNETISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PARENCHYMA; PHLEBOTOMY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; TRANSFERRIN BLOOD LEVEL; URINARY EXCRETION;

BIOPSY; FERRITINS; HUMANS; IRON; IRON OVERLOAD; LIVER; MAGNETIC RESONANCE IMAGING; MYOCARDIUM;

EID: 1642313571     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2004.04838.x     Document Type: Review

References (152)

1. Aldouri, M.A., Wonke, B., Hoffbrand, A.V., Flynn, D.M., Laulicht, M., Fenton, L.A., Scheuer, P.J., Kibbler, C.C., Allwood, C.A., Brown, D. & Thomas, H.C. (1987) Iron state and hepatic disease in patients with thalassaemia major, treated with long term subcutaneous desferrioxamine. Journal of Clinical Pathology, 40, 1353-1359.
2. Ambrosetto, P., Zucchini, S., Cicognani, A. & Cacciari, E. (1998) MR findings in pituitary haemosiderosis. Pediatric Radiology, 28, 288-289.
3. Ambu, R., Crisponi, G., Sciot, R., Van Eyken, P., Parodo, G., Iannelli, S., Marongiu, F., Silvagni, R., Nurchi, V., Costa, V. Faa, G. & Desmet, V.J. (1995) Uneven hepatic iron and phosphorus distribution in beta-thalassemia. Journal of Hepatology, 23, 544-549.
4. Anderson, L.J., Holden, S., Davis, B., Prescott, E., Charrier, C.C., Bunce, N.H., Firmin, D.N., Wonke, B., Porter, J., Walker, J.M. & Pennell, D.J. (2001) Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. European Heart Journal, 22, 2171-2179.
5. Anderson, L.J., Wonke, B., Prescott, E., Holden, S., Walker, J.M. & Pennell, D.J. (2002) Comparison of effect of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia. Lancet, 360, 516-520.
6. Angelucci, E., Baronciani, D., Lucarelli, G., Baldassarri, M., Galimberti, M., Giardini, C., Martinelli, F., Polchi, P., Polizzi, V., Ripalti, M. & Muretto, P. (1995) Needle liver biopsy in thalassaemia: analyses of diagnostic accuracy and safety in 1184 consecutive biopsies. British Journal of Haematology, 89, 757-761.
7. Angelucci, E., Giovagnoni, A., Valeri, G., Paci, E., Ripalti, M., Muretto, P., McLaren, C., Brittenham, G.M. & Lucarelli, G. (1997) Limitations of magnetic resonance imaging in measurement of hepatic iron. Blood, 90, 4736-4742.
8. Angelucci, E., Brittenham, G.M., McLaren, C.E., Ripalti, M., Baronciani, D., Giardini, C., Galimberti, M., Polchi, P. & Lucarelli, G. (2000) Hepatic iron concentration and total body iron stores in thalassemia major. New England Journal of Medicine, 343, 327-331.
9. Argyropoulou, M.I., Metafratzi, Z., Kiortsis, D.N., Bitsis, S., Tsatsoulis, A. & Efremidis, S. (2000) T2 relaxation rate as an index of pituitary iron overload in patients with beta-thalassemia major. American Journal of Roentgenology, 175, 1567-1569.
10. Argyropoulou, M.I., Kiortsis, D.N. & Efremidis, S.C. (2003) MRI of the liver and the pituitary gland in patients with beta-thalassemia major: does hepatic siderosis predict pituitary iron deposition? European Radiology, 13, 12-16.
11. Baldus, W.P., Fairbanks, V.F., Dickson, E.R. & Baggenstoss, A.H. (1978) Deferoxamine-chelatable iron in hemochromatosis and other disorders of iron overload. Mayo Clinic Proceedings, 53, 157-165.
12. Baraldi-Junkins, C., Levin, H.R., Kasper, E.K., Rayburn, B.K., Herskowitz, A. & Baughman, K.L. (1993) Complications of endomyocardial biopsy in heart transplant patients. Journal of Heart and Lung Transplantation, 12, 63-67.
13. Barosi, G., Arbustini, E., Gavazzi, A., Grasso, M. & Pucci, A. (1989) Myocardial iron grading by endomyocardial biopsy. A clinico-pathologic study on iron overloaded patients. European Journal of Haematology, 42, 382-388.
14. Barry, M. (1974) Liver iron concentration, stainable iron and total body storage iron. Gut, 15, 411-415.
15. Barry, M. & Sherlock, S. (1971) Measurement of liver-iron concentration in needle biopsy specimens. Lancet, I, 100-103.
16. Barry, M., Flynn, D.M., Letsky, E.A. & Risdon, R.A. (1974) Long-term chelation therapy in thalassaemia major: effect on liver iron concentration, liver histology, and clinical progress. British Medical Journal, 2, 16-20.
17. Bassett, M.L., Halliday, J.W. & Powell, L.W. (1986) Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology, 6, 24-29.
18. Bauman, J.H. & Harris, J.W. (1967) Estimation of hepatic iron stores by in-vivo measurements of magnetic susceptibility. Journal of Laboratory and Clinical Medicine, 70, 246-257.
19. Baynes, R., Bezwoda, W., Bothwell, T. Khan, Q. & Mansoor, N. (1986) The non-immune inflamatory response: Serial changes in plasma iron, iron-binding capacity, lactoferrin, ferritin, and C-reactive protein. Scandinavian Journal of Clinical and Laboratory Investigation, 46, 695-704.
20. Berkovitch, M., Bistritzer, T., Milone, S.D., Perlman, K., Kucharczyk, W. & Olivieri, N.F. (2000) Iron deposition in the anterior pituitary in homozygous beta-thalassemia: MRI evaluation and correlation with gonadal function. Journal of Pediatric Endocrinology and Metabolism, 13, 179-184.
21. Bonkovsky, H.L., Slaker, D.P., Bills, E.B. & Wolf, D.C. (1990) Usefulness and limitations of laboratory and hepatic imaging studies in iron-storage disease. Gastroenterology, 99, 1079-1091.
22. Bonkovsky, H.L., Rubin, R.B., Cable, E.E., Davidoff, A., Rijcken, T.H. & Stark, D.D. (1999) Hepatic iron concentration: noninvasive estimation by means of MR imaging techniques. Radiology, 212, 227-234.
23. Bonetti, M.G., Castriota-Scanderbeg, A., Criconia, G.M., Mazza, P., Sacco, M., Amurri, B. & Masi, C. (1996) Hepatic iron overload in thalassemic patients: proposal and validation of MRI method of assessment. Pediatric Radiology, 26, 650-656.
24. Bothwell, T., Charlton, R.W., Cook, J.D. & Finch, C.A. (1979) In: Iron Metabolism in Man, pp. 105-115. Blackwell Scientific Publications, Oxford.
25. Breuer, W., Epsztejn, S. & Cabantchik, Z.I. (1995) Iron acquired from tranferrin by K562 cells is delivered into the cytoplasmic pool of chelatable iron (II). Journal of Biological Chemistry, 270, 24209.
26. Breuer, W., Ronson, A., Slotki, I.N., Abramov, A., Hershko, C. & Cabantchik, Z.I. (2000) The assessment of serum nontransferrin-bound iron in chelation therapy and iron supplementation. Blood, 95, 2975-2982.
27. Brissot, P., Bourel, M., Herry, D., Verger, J.P., Messner, M., Beaumont, C., Regnouard, F., Ferrand, B. & Simon, M. (1981) Assessment of liver iron content in 271 patients: a reevaluation of direct and indirect methods. Gastroenterology, 80, 557-565.
28. Brittenham, G.M. & Badman, D.G. (2003) Noninvasive measurement of iron: report of an NIDDK workshop. Blood, 101, 15-19.
29. Brittenham, G.M., Farrell, D.E., Harris, J.W., Feldman, E.S., Danish, E.H., Muir, W.A., Tripp, J.H. & Bellon, E.M. (1982) Magnetic-susceptibility measurement of human iron stores. New England Journal of Medicine, 307, 1671-1675.
30. Brittenham, G.M., Cohen, A.R., McLaren, C.E., Martin, M.B., Griffith, P.M., Nienhuis, A.W., Young, N.S., Allen, C.J., Farrell, D.E. & Harris, J.W. (1993) Hepatic iron stores and plasma ferritin concentration in patients with sickle cell anemia and thalassemia major. American Journal of Hematology, 42, 81-85.
31. Brittenham, G.M., Griffith, P.M., Nienhuis, A.W., McLaren, C.E., Young, N.S., Tucker, E.E., Allen, C.J., Farrell, D.E. & Harris, J.W. (1994) Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. New England Journal of Medicine, 331, 567-573.
32. Brittenham, G.M., Sheth, S., Allen, C.J. & Farrell, D.E. (2001) Non-invasive methods for quantitative assessment of transfusional iron overload in sickle cell disease. Seminars in Hematology, 38, 37-56.
33. Buja, L.M. & Roberts, W.C. (1971) Iron in the heart. Etiology and clinical significance. American Journal of Medicine, 51, 209-221.
34. Canedo, M.I. (1993) Comments on complications of endomyocardial biopsy in heart transplanted patients. Journal of Heart and Lung Transplantation, 12, 887-888.
35. Cavill, I. (1999) Iron status as measured by serum ferritin: the marker and its limitations. American Journal of Kidney Diseases, 34, S12-S17.
36. Cazzola, M., Borgna-Pignatti, C., de Stefano, P., Bergamaschi, G., Bongo, I.G., Dezza, L. & Avato, F. (1983) Internal distribution of excess iron and sources of serum ferritin in patients with thalassemia. Scandinavian Journal of Haematology, 30, 289-296.
37. Chatterjee, R. & Katz, M. (2000) Reversible hypogonadotrophic hypogonadism in sexually infantile male thalassaemic patients with transfusional iron overload. Clinical Endocrinology (Oxford), 53, 33-42.
38. Chatterjee, R., Katz, M., Oatridge, A., Bydder, G.M. & Porter, J.B. (1998) Selective loss of anterior pituitary volume with severe pituitary-gonadal insufficiency in poorly compliant male thalassemic patients with pubertal arrest. Annals of the New York Academy of Sciences, 850, 479-482.
39. Chezmar, J.L., Nelson, R.C., Malko, J.A. & Bernardino, M.E. (1990) Hepatic iron overload: diagnosis and quantification by noninvasive imaging. Gastrointestinal Radiology, 15, 27-31.
40. Clark, P.R. & St Pierre, T.G. (2000) Quantitative mapping of transverse relaxivity (1/T(2)) in hepatic iron overload: a single spin-echo imaging methodology. Magnetic Resonance Imaging, 18, 431-438.
41. Clark, P.R., Chua-anusorn, W. & St Pierre, T.G. (2003a) Biexponential proton transverse relaxation rate (R2) image analysis using RF field intensity-weighted spin density projection: potential for R2 measurement of iron-loaded liver. Magnetic Resonance Imaging, 21, 519-530.
42. Clark, P.R., Chua-Anusorn, W. & St Pierre, T.G. (2003b) Proton transverse relaxation rate (R2) images of iron-loaded liver tissuepping local tissue iron concentrations with MRI. Magnetic Resonance in Medicine, 49, 572-575.
43. Cook, J.D., Finch, C.A. & Smith, N.J. (1976) Evaluation of the iron status of a population. Blood, 48, 449-455.
44. Crichton, R.R. & Ward, R.J. (1995) Iron species in iron homeostasis and toxicity. Analyst, 120, 693-697.
45. Cutler, D.J., Isner, J.N., Bracey, A.W., Hufnagel, G.A., Conrad, P.W., Roberts, W.C., Kerwin, D.M. & Weintraub, A.M. (1980) American Journal of Medicine, 69, 923-927.
46. Deugnier, Y.M., Loreal, O., Turlin, B., Guyader, D., Jouanolle, H., Moirand, R., Jacquelinet, C. & Brissot, P. (1992) Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations. Gastroenterology, 102, 2050-2059.
47. Dixon, R.M., Styles, P., al-Refaie, F.N., Kemp, G.J., Donohue, S.M., Wonke, B., Hoffbrand, A.V., Radda, G.K. & Rajagopalan, B. (1994) Assessment of hepatic iron overload in thalassemic patients by magnetic resonance spectroscopy. Hepatology, 19, 904-910.
48. Edelman, R.R., Johnson, K. & Buxton, R. (1986) MR of hemorrhage: a new approach. American Journal of Neuroradiology, 7, 751-756.
49. Emond, M.J., Bronner, M.P., Carlson, T.H., Lin, M., Labbe, R.F. & Kowdley, K.V. (1999) Quantitative study of the variability of hepatic iron concentrations. Clinical Chemistry, 45, 340-346.
50. Engelhardt, R., Langkowski, J.H., Fischer, R., Nielsen, P., Kooijman, H., Heinrich, H.C. & Bucheler, E. (1994) Liver iron quantification: studies in aqueous iron solutions, iron overloaded rats, and patients with hereditary hemochromatosis. Magnetic Resonance Imaging, 12, 999-1007.
51. Ernst, O., Sergent, G., Bonvarlet, P., Canva-Delcambre, V., Paris, J.C. & L'Hermine, C. (1997) Hepatic iron overload: diagnosis and quantification with MR imaging. American Journal of Roentgenology, 168, 1205-1208.
52. Feder, J.N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D.A., Basava, A., Dormishian, F., Domingo, R. Jr., Ellis, M.C., Fullan, A., Hinton, L.M., Jones, N.L., Kimmel, B.E., Kronmal, G.S., Lauer, P., Lee, V.K., Loeb, D.B., Mapa, F.A., McClelland, E., Meyer, N.C., Mintier, G.A., Moeller, N., Moore, T., Morikang, E., Prass, C.E., Quintana, L., Starnes, S.M., Schatzman, R.C., Brunke, K.J., Drayna, D.T., Risch, N.J., Bacon, B.R. & Wolff, R.K. (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nature Genetics, 13, 399-408.
53. Fenzi, A., Bortolazzi, M., Marzola, P. & Colombari, R. (2001) In vivo investigation of hepatic iron overload in rats using T2 maps: quantification at high intensity field (4.7-T). Journal of Magnetic Resonance Imaging, 13, 392-396.
54. Fenzi, A., Bortolazzi, M. & Marzola, P. (2003) Comparison between signal-to-noise ratio, liver-to-muscle ratio, and 1/T2 for the non-invasive assessment of liver iron content by MRI. Journal of Magnetic Resonance Imaging, 17, 589-592.
55. Finch, C., Bellotti, V., Stray, S., Lipschitz, D.A., Cook, J.D. & Pippard, M.J. (1986) Plasma ferritin determination as a diagnostic tool. Western Journal of Medicine, 145, 657-663.
56. Fischer, R., Engelhardt, R., Nielsen, P., Gabbe, E.E., Heinrich, H.C., Schmiegel, W.H. & Wurbs, D. (1992) Liver iron quantification in the diagnosis and therapy control of iron overload patients. In: Advances in Biomagnetism: Clinical Aspects (ed. by M. Hoke et al), pp. 585-588. Elsevier, Amsterdam.
57. Fischer, R., Tiemann, C.D., Engelhardt, R., Nielsen, P., Durken, M., Gabbe, E.E. & Janka, G.E. (1999) Assessment of iron stores in children with transfusion siderosis by biomagnetic liver susceptometry. American Journal of Hematology, 60, 289-299.
58. Fischer, R., Longo, F., Nielsen, P., Engelhardt, R., Hider, R.C. & Piga, A. (2003) Monitoring long-term efficacy of iron chelation therapy by deferiprone and desferrioxamine in patients with beta-thalassaemia major: application of SQUID biomagnetic liver susceptometry. British Journal of Haematology, 121, 938-948.
59. Fitchett, D.H., Coltart, D.J., Littler, W.A., Leyland, M.J., Trueman, T., Gozzard, D.I. & Peters, T.J. (1980) Cardiac involvement in secondary haemochromatosis: a catheter biopsy study and analysis of myocardium. Cardiovascular Research, 14, 719-724.
60. Fletcher, L.M., Dixon, J.L., Purdie, D.M., Powell, L.W. & Crawford, D.H. (2002) Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis. Gastroenterology, 122, 281-289.
61. Frahm, J., Haase, A. & Matthaei, D. (1986) Rapid NMR imaging of dynamic processes using the FLASH technique. Magnetic Resonance in Medicine, 3, 321-327.
62. Fujisawa, I., Morikawa, M., Nakano, Y. & Konishi, J. (1988) Hemochromatosis of the pituitary gland: MR imaging. Radiology, 168, 213-214.
63. Galia, M., Midiri, M., Bartolotta, V., Morabito, A., Rizzo, M., Mangiagli, A., Malizia, R., Borsellino, Z., Capra, M., D'Ascola, D.G., Magnano, C., Gerardi, C., Rigano, P. & Maggio, A. (2003) Potential myocardial iron content evaluation by magnetic resonance imaging in thalassemia major patients treated with Deferoxamine or Deferiprone during a randomized multicenter prospective clinical study. Hemoglobin, 27, 63-76.
64. Gandon, Y., Guyader, D., Heautot, J.F., Reda, M.I., Yaouanq, J., Buhe, T., Brissot, P., Carsin, M. & Deugnier, Y. (1994) Hemochromatosis: diagnosis and quantification of liver iron with gradient-echo MR imaging. Radiology, 193, 533-538.
65. Gomori, J.M., Grossman, R.I. & Drott, H.R. (1988) MR relaxation times and iron content of thalassemic spleens: an in vitro study. American Journal of Roentgenology, 150, 567-569.
66. Gomori, J.M., Horev, G., Tamary, H., Zandback, J., Kornreich, L., Zaizov, R., Freud, E., Krief, O., Ben-Meir, J., Rotem, H. Kuspet, M., Rosen, P., Rachmilewitz, E.A., Loewenthal, E. & Gorodetsky, R. (1991) Hepatic iron overload: quantitative MR imaging. Radiology, 179, 367-369.
67. Gossuin, Y., Roch, A., Muller, R.N. & Gillis, P. (2000) Relaxation induced by ferritin and ferritin-like magnetic particles: the role of proton exchange. Magnetic Resonance in Medicine, 43, 237-243.
68. Gutteridge, J.M., Rowley, D.A., Griffiths, E. & Halliwell, B. (1985) Low-molecular-weight iron complexes and oxygen radical reactions in idiopathic haemochromatosis. Clinical Science, 68, 463-467.
69. Guyader, D., Gandon, Y., Deugnier, Y., Jouanolle, H., Loreal, O., Simon, M., Bourel, M., Carsin, M. & Brissot, P. (1989) Evaluation of computed tomography in the assessment of liver iron overload. A study of 46 cases of idiopathic hemochromatosis. Gastroenterology, 97, 737-743.
70. Harmatz, P., Butensky, E., Quirolo, K., Williams, R., Ferrell, L., Moyer, T., Golden, D., Neumayr, L. & Vichinsky, E. (2000) Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy. Blood, 96, 76-79.
71. Harrison, P.M. (1977) Ferritin an iron-storage molecule. Seminars in Hematology, 14, 55-70.
72. Harrison, P.M. & Arosio, P. (1996) The ferritins: molecular properties, iron storage function and cellular regulation. Biochimica et Biophysica Acta, 1275, 161-203.
73. Haskins, D., Stevens, A.R. & Finch, S.C. (1952) Iron metabolism. Iron stores in man as measured by phlebotomy. Journal of Clinical Investigation, 31, 543-547.
74. Hentze, M.W. & Kuhn, C. (1996) Molecular control of vertebrate iron metabolisme: mRNA-based regulatory circuits operated by iron, nitric oxide, and andoxidative stress. Proceedings of the National Academy of Sciences of the United States of America, 93, 8175-8182.
75. Herbert, V., Jayatilleke, E., Shaw, S., Rosman, A.S., Giardina, P., Grady, R.W., Bowman, B. & Gunter, E.W. (1997) Serum ferritin iron, a new test, measures human body iron stores unconfounded by inflammation. Stem Cells, 15, 291-296.
76. Hernandez, R.J., Sarnaik, S.A., Lande, I., Aisen, A.M., Glazer, G.M., Chenevert, T. & Martel, W. (1988) MR evaluation of liver iron overload. Journal of Computer Assisted Tomography, 12, 91-94.
77. Hershko, C. & Rachmilewitz, E.A. (1979) Mechanism of desferrioxamine-induced iron excretion in thalassaemia. British Journal of Haematology, 42, 125-132.
78. Hershko, C., Cook, J.D. & Finch, C.A. (1972) Storage iron kinetics. II. The uptake of hemoglobin iron by hepatic parenchymal cells. Journal of Laboratory and Clinical Medicine, 80, 624-634.
79. Hershko, C., Link, G. & Cabantchik, I. (1998a) Pathophysiology of iron overload. Annals of the New York Academy of Sciences, 850, 191-201.
80. Hershko, C., Konijn, A.M. & Link, G. (1998b) Iron chelators for thalassaemia. British Journal of Haematology, 101, 399-406.
81. Howard, J.M., Ghent, C.N., Carey, L.S., Flanagan, P.R. & Valberg, L.S. (1983) Diagnostic efficacy of hepatic computed tomography in the detection of body iron overload. Gastroenterology, 84, 209-215.
82. Jacobs, A. (1977) Iron overload-clinical and pathologic aspects. Seminars in Hematology, 14, 89-113.
83. Jensen, P.D., Bagger, J.P., Jensen, F.T., Baandrup, U., Christensen, T. & Ellegaard, J. (1993) Heart transplantation in a case of juvenile hereditary haemochromatosis followed up by MRI and endomyocardial biopsies. European Journal of Haematology, 51, 199-205.
84. Jensen, P.D., Jensen, F.T., Christensen, T. & Ellegaard, J. (1994) Non-invasive assessment of tissue iron overload in the liver by magnetic resonance imaging. British Journal of Haematology, 87, 171-184.
85. Jensen, P.D., Jensen, F.T., Christensen, T. & Ellegaard, J. (1995) Evaluation of transfusional iron overload before and during iron chelation by magnetic resonance imaging of the liver and determination of serum ferritin in adult non-thalassaemic patients. British Journal of Haematology, 89, 880-889.
86. Jensen, P.D., Heickendorff, L., Pedersen, B., Bendix-Hansen, K., Jensen, F.T., Christensen, T., Boesen, A.M. & Ellegaard, J. (1996) The effect of iron chelation on haemopoiesis in MDS patients with transfusional iron overload. British Journal of Haematology, 94, 288-2951.
87. Jensen, P.D., Jensen, F.T., Christensen, T., Heickendorff, L., Jensen, L.G. & Ellegaard, J. (2001) Indirect evidence for the potential ability of magnetic resonance imaging to evaluate the myocardial iron content in patients with transfusional iron overload. Magma, 12, 153-166.
88. Jensen, P.D., Jensen, F.T., Christensen, T., Eiskjaer, H., Baandrup, U. & Niclsen, J.L. (2003a) Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool. Blood, 101, 4632-4639.
89. Jensen, P.D., Jensen, F.T., Christensen, T., Nielsen, J.L. & Ellegaard, J. (2003b) Relationship between hepatocellular injury and transfusional iron overload prior to and during iron chelation with desferrioxamine: a study in adult patients with acquired anemias. Blood, 101, 91-96.
90. Johntton, D.L., Rice, L., Vick, G.W., III, Hedrick, T.D. & Rokey, R. (1989) Assessment of tissue iron overload by nuclear magnetic resonance imaging. American Journal of Medicine, 87, 40-47.
91. Jones, P.A.E., Miller, F.M. & Worwood, M. (1973) Ferritinaemia in leukaemia and Hodgkin's disease. British Journal of Cancer, 27, 212-217.
92. Kaltwasser, J.P., Gottschalk, R., Schalk, K.P. & Hartl, W. (1990) Non-invasive quantitation of liver iron-overload by magnetic resonance imaging. British Journal of Haematology, 74, 360-363.
93. Kew, M.C., Torrance, D.J. & Derman, D.P. (1978) Serum and tumor ferritins in in primary liver cancer. Gut, 19, 294-299.
94. Klausner, R.D., Rouault, T.A. & Harford, J.B. (1993) Regulating the fate of mRNA: the control of cellular iron metabolism. Cell, 72, 19-28.
95. Letsky, E.A., Miller, F., Worwood, M. & Flynn, D.M. (1974) Serum ferritin in children with thalassaemia regularly transfused. Journal of Clinical Pathology, 27, 652-655.
96. Long, J.A. Jr., Doppman, J.L., Nienhus, A.W. & Mills, S.R. (1980) Computed tomographic analysis of beta-thalassemic syndromes with hemochromatosis: pathologic findings with clinical and laboratory correlations. Journal of Computer Assisted Tomography, 4, 159-165.
97. Macfarlane, J.D., Vreugdenhil, G.R., Doornbos, J. & van der Voet, G.B. (1995) Idiopathic haemochromatosis: magnetic resonance signal intensity ratios permit non-invasive diagnosis of low levels of iron overload. Netherlands Journal of Medicine, 47, 49-53.
98. Mavrogeni, S.I., Gotsis, E.D., Markussis, V., Tsekos, N., Politis, C., Vretou, E. & Kermastinos, D. (1998a) T2 relaxation time study of iron overload in b-thalassemia. Magma, 6, 7-12.
99. Mavrogeni, S.I., Maris, T., Gouliamos, A., Vlahos, L. & Kremastinos, D.T. (1998b) Myocardial iron deposition in beta-thalassemia studied by magnetic resonance imaging. International Journal of Cardiac Imaging, 14, 117-122.
100. Mendler, M.H., Bouillet, P., Le Sidaner, A., Lavoine, E., Labrousse, F., Sautereau, D. & Pillegand, B. (1998) Dual-energy CT in the diagnosis and quantification of fatty liver: limited clinical value in comparison to ultrasound scan and single-energy CT, with special reference to iron overload. Journal of Hepatology, 28, 785-794.
101. Miaux, Y., Daurelle, P. & Zagdanski, M. (1995) MRI in haemachromatosis:pituitary versus testicular iron deposition in five patients with hypogonadism. European Radiology, 5, 165-171.
102. Mitnick, J.S., Bosniak, M.A., Megibow, A.J., Karpatkin, M., Feiner, H.D., Kutin, N., Van Natta, F. & Piomelli, S. (1981) CT in B-thalassemia: iron deposition in the liver, spleen, and lymph nodes. American Journal of Roentgenology, 136, 1191-1194.
103. Modell, C.B. & Beck, J. (1974) Long-term desferrioxamine therapy in thalassemia. Annals of the New York Academy of Sciences, 232, 201-210.
104. Modell, B. & Berdoukas, V. (1981) The clinical Approach to Thalassaemia. Grune and Stratton, New York.
105. Niederau, C., Fischer, R., Sonnenberg, A., Stremmel, W., Trampisch, H.J. & Strohmeyer, G. (1985) Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. New England Journal of Medicine, 313, 1256-1262.
106. Nielsen, P., Engelhardt, R., Fischer, R., Heinrich, H.C., Langkowski, J.H. & Bucheler, E. (1992) Noninvasive liver-iron quantification by computed tomography in iron-overloaded rats. Investigative Radiology, 27, 312-317.
107. Nielsen, P., Fischer, R., Engelhardt, R., Tondury, P., Gabbe, E.E. & Janka, G.E. (1995) Liver iron stores in patients with secondary haemosiderosis under iron chelation therapy with deferoxamine or deferiprone. British Journal of Haematology, 91, 827-833.
108. Nielsen, P., Gunther, U., Durken, M., Fischer, R. & Dullmann, J. (2000) Serum ferritin iron in iron overload and liver damage: correlation to body iron stores and diagnostic relevance. Journal of Laboratory and Clinical Medicine, 135, 413-418.
109. Nielsen, P., Engelhardt, R., Dullmann, J. & Fischer, R. (2002) Non-invasive liver iron quantification by SQUID-biosusceptometry and serum ferritin iron as new diagnostic parameters in hereditary hemochromatosis. Blood Cells, Molcules, and Diseases, 29, 451-458.
110. Nitti, D., Fabris, C. & Del Favero, G. (1982) Serum ferritin in pancreatic disease. Digestion, 25, 258-262.
111. O'Brien, R.T. (1977) Iron overload: clinical and pathologic aspects in pediatrics. Seminars in Hematology, 14, 115-125.
112. Olivieri, N.F. & Brittenham, G.M. (1997) Iron-chelation therapy and the treatment of thalassemia. Blood, 89, 739-761.
113. Olivieri, N.F., Nathan, D.G., MacMillan, J.H., Wayne, A.S., Liu, P.P., McGee, A., Martin, M., Koren, G. & Cohen, A.R. (1994) Survival in medically treated patients with homozygous beta-thalassemia. New England Journal of Medicine, 331, 574-578.
114. Olivieri, N.F., Brittenham, G.M., McLaren, C.E., Templeton, D.M., Cameron, R.G., McClelland, R.A., Burt, A.D. & Fleming, K.A. (1998) Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major. New England Journal of Medicine, 339, 417-423.
115. Olson, L.J., Edwards, W.D., McCall, J.T., Ilstrup, D.M. & Gersh, B.J. (1987) Cardiac iron deposition in idiopathic hemochromatosis: histologic and analytic assessment of 14 hearts from autopsy. Journal of the American College of Cardiology, 10, 1239-1243.
116. Overmoyer, B.A., McLaren, C.E. & Brittenham, G.M. (1987) Uniformity of liver density and nonheme (storage) iron distribution. Archives of Pathology and Laboratory Medicine, 111, 549-554.
117. Papakonstantinou, O.G., Maris, T.G., Kostaridou, V., Gouliamos, A.D., Koutoulas, G.K., Kalovidouris, A.E., Papavassiliou, G.B., Kordas, G., Kattamis, C., Vlahos, L.J. & Papavassiliou, C.G. (1995) Assessment of liver iron overload by T2-quantitative magnetic resonance imaging: correlation of T2-QMRI measurements with serum ferritin concentration and histologic grading of siderosis. Magnetic Resonance Imaging, 13, 967-977.
118. Papanikolaou, N., Ghiatas, A., Kattamis, A., Ladis, C., Kritikos, N. & Kattamis, C. (2000) Non-invasive myocardial iron assessment in thalassaemic patients. T2 relaxometry and magnetization transfer ratio measurements. Acta Radiologica, 41, 348-351.
119. Pippard, M. (1989) Measurement of iron status. Progress in Clinical and Biological Research, 309, 705-713.
120. Pippard, M.J. (1990) Iron metabolism and iron chelation in the thalassaemia disorders. Haematologica, 75(Suppl. 5), 66-71.
121. Pippard, M.J. & Weatherall, D.J. (1984) Iron absorption in non-transfused iron loading anaemias: prediction of risk for iron loading, and response to iron chelation treatment, in beta thalassaemia intermedia and congenital sideroblastic anaemias. Haematologia (Budapest), 17, 17-24.
122. Pippard, M.J., Callender, S.T. & Finch, C.A. (1982) Ferrioxamine excretion in iron-loaded man. Blood, 60, 288-294.
123. Pootrakul, P., Kitcharoen, K., Yansukon, P., Wasi, P., Fucharoen, S., Charoenlarp, P., Brittenham, G., Pippard, M.J. & Finch, C.A. (1988) The effect of erythroid hyperplasia on iron balance. Blood, 71, 1124-1129.
124. Porter, J.B. (2001) Practical management of iron overload. British Journal of Haematology, 115, 239-252.
125. Prieto, J., Barry, M. & Sherlock, S. (1975) Serum ferritin in patients with iron overload and with acute and chronic liver diseases. Gastroenterology, 68, 525-533.
126. Raja, K.B., Pippard, M.J., Simpson, R.J. & Peters, T.J. (1986) Relationship between erythropoiesis and the enhanced intestinal uptake of ferric iron in hypoxia in the mouse. British Journal of Haematology, 64, 587-593.
127. Risdon, R.A., Barry, M. & Flynn, D.M. (1975) Transfusional iron overload: the relationship between tissue iron concentration and hepatic fibrosis in thalassaemia. Journal of Pathology, 116, 83-95.
128. Rocchi, E., Cassanelli, M., Borghi, A., Paolillo, F., Pradelli, M., Casalgrandi, G., Burani, A. & Gallo, E. (1993) Magnetic resonance imaging and different levels of iron overload in chronic liver disease. Hepatology, 17, 997-1002.
129. Roeser, H.P., Halliday, J.W., Sizemore, D.J. Nikles, A. & Willgoss, D.. (1980) Serum ferritin in ascorbic acid deficiency. British Journal of Haematology, 45, 459-466.
130. Schafer, A.I., Cheron, R.G., Dluhy, R., Cooper, B., Gleason, R.E., Soeldner, J.S. & Bunn, H.F. (1981) Clinical consequences of acquired transfusional iron overload in adults. New England Journal of Medicine, 304, 319-324.
131. Sheth, S. (2003) SQUID biosusceptometry in the measurement of hepatic iron. Pediatric Radiology, 33, 373-377.
132. Sparacia, G., Midiri, M., D'Angelo, P. & Lagalla, R. (1999) Magnetic resonance imaging of the pituitary gland in patients with secondary hypogonadism due to transfusional hemochromatosis. Magma, 8, 87-90.
133. Sparacia, G., Iaia, A., Banco, A., D'Angelo, P. & Lagalla, R. (2000) Transfusional hemochromatosis: quantitative relation of MR imaging pituitary signal intensity reduction to hypogonadotropic hypogonadism. Radiology, 215, 818-823.
134. Stark, D.D., Moseley, M.E., Bacon, B.R., Moss, A.A., Goldberg, H.I., Bass, N.M. & James, T.L. (1985) Magnetic resonance imaging and spectroscopy of hepatic iron overload. Radiology, 154, 137-142.
135. Telfer, P.T., Prestcott, E., Holden, S., Walker, M., Hoffbrand, A.V. & Wonke, B. (2000) Hepatic iron concentration combined with long-term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major. British Journal of Haematology, 110, 971-977.
136. Thalassaemia International Federation (TIF) (2000) Guidelines for Clinical Management of Thalassaemia (ed. by N. Cappellini, A. Cohen, A. Eleftheriou, A. Piga & J. Porter). TIF, Nicosia, Cyprus.
137. Thomsen, C., Wiggers, P., Ring-Larsen, H., Christiansen, E., Dalhoj, J., Henriksen, O. & Christoffersen, P. (1992) Identification of patients with hereditary haemochromatosis by magnetic resonance imaging and spectroscopic relaxation time measurements. Magnetic Resonance Imaging, 10, 867-879.
138. Torrance, J.D. & Bothwell, T. (1980) Tissue iron stores. In: Methods in Haematology, Vol. 1 (ed. by J.D. Cook), pp. 90-115. Churchill Livingstone, New York.
139. Toth, I., Rogers, J.T. & McPhee, J.A. (1995) Ascorbic acid enhances iron-induced ferrjtin translation in human leukemia and hepatorna cells. Journal of Biological Chemistry, 270, 2846-2852.
140. Villeneuve, J.P., Bilodeau, M., Lepage, R., Cote, J. & Lefebvre, M. (1996) Variability in hepatic iron concentration measurement from needle-biopsy specimens. Journal of Hepatolology, 25, 172-177.
141. Vymazal, J., Hajek, M., Patronas, N., Giedd, J.N., Bulte, J.W., Baumgarner, C., Tran, V. & Brooks, R.A. (1995) The quantitative relation between T1-weighted and T2-weighted MRI of normal gray matter and iron concentration. Journal of Magnetic Resonance Imaging, 5, 554-560.
142. Vymazal, J., Brooks, R.A., Bulte, J.W., Gordon, D. & Aisen, P. (1998) Iron uptake by ferritin: NMR relaxometry studies at low iron loads. Journal of Inorganic Biochemistry, 71, 153-157.
143. Vymazal, J., Urgosik, D. & Bulte, J.W. (2000) Differentiation between hemosiderin-and ferritin-bound brain iron using nuclear magnetic resonance and magnetic resonance imaging. Cellular and Molecular Biology (Noisy-le-grand), 46, 835-842.
144. Wacker, C.M., Bock, M., Hartlep, A.W., Beck, G., van Kaick, G., Ertl, G., Bauer, W.R. & Schad, L.R. (1999) Changes in myocardial oxygenation and perfusion under pharmacological stress with dipyridamole: assessment using T*2 and T1 measurements. Magnetic Resonance in Medicine, 41, 686-695.
145. Wang, Z.J., Haselgrove, J.C., Martin, M.B., Hubbard, A.M., Li, S., Loomes, K., Moore, J.R., Zhao, H. & Cohen, A.R. (2002) Evaluation of iron overload by single voxel MRS measurement of liver T2. Journal of Magnetic Resonance Imaging, 15, 395-400.
146. Weiss, G., Houston, T., Kastner, S., Jöhrer, K., Grünewald, K. & Brock, J.H. (1997) Regulation of cellular iron metabolism by erythropoietin: activation of iron-regulatory protein, and upregulation of transferrin receptor expression in erythroid cells. Blood, 89, 680-687.
147. Westwood, M., Anderson, L.J., Firmin, D.N., Gatehouse, P.D., Charrier, C.C., Wonke, B. & Pennell, D.J. (2003) A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. Journal of Magnetic Resonance Imaging, 18, 33-39.
148. Wielopolski, L. & Zaino, E.C. (1992) Noninvasive in-vivo measurement of hepatic and cardiac iron. Journal of Nuclear Medicine, 33, 1278-1282.
149. Wixom, R.L., Prutkin, L. & Munro, H.N. (1980) Hemosiderin: nature, formation, and significance. International Review of Experimental Pathology, 22, 193-225.
150. Wohler, F. (1964) Diagnosis of iron storage disease with desferrioxamine (Desferal test). Acta Haematologica, 32, 321-337.
151. Worwood, M. (1997) The laboratory assessment of iron status - an update. Clinica Chimica Acta, 259, 3-23.
152. Worwood, M., Cragg, S.J., Jacobs, A., McLaren, C., Ricketts, C. & Economidou, J. (1980) Binding of serum ferritin to concanavalin A: patients with homozygous beta thalassaemia and transfusional iron overload. British Journal of Haematology, 46, 409-416.